Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Akebia Therapeutics (NQ: AKBA ) 1.280 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Akebia Therapeutics < Previous 1 2 3 4 5 6 Next > AKBA Stock Earnings: Akebia Therapeutics Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 AKBA stock results show that Akebia Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 10, 2024 Via Benzinga Akebia Therapeutics Surges on FDA Approval for Anemia Treatment April 03, 2024 Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia Via MarketBeat Exposures Product Safety 12 Health Care Stocks Moving In Friday's Intraday Session March 29, 2024 Via Benzinga Recap: Akebia Therapeutics Q4 Earnings March 14, 2024 Via Benzinga Earnings Preview For Akebia Therapeutics March 13, 2024 Via Benzinga Earnings Outlook For Akebia Therapeutics November 07, 2023 Via Benzinga Earnings Outlook For Akebia Therapeutics August 24, 2023 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session March 28, 2024 Via Benzinga Akebia Therapeutics Inc. (NASDAQ: AKBA) is One of Thursday Morning’s Most Active Stocks March 28, 2024 Via Investor Brand Network FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia March 28, 2024 The FDA-approved Vafseo tablets by Akebia Therapeutics for managing anemia in adult dialysis patients with chronic kidney disease. Learn about its once-daily oral HIF-PH inhibitor and global approval... Via Benzinga Exposures Product Safety Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket March 28, 2024 Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 28, 2024 Via Benzinga Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday March 27, 2024 U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Friday's Intraday Session March 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 15, 2024 Via Benzinga Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session March 26, 2024 Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 15, 2024 It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning! Via InvestorPlace AKBA Stock Earnings: Akebia Therapeutics Beats Revenue for Q4 2023 March 14, 2024 AKBA stock results show that Akebia Therapeutics beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's After-Market Session March 14, 2024 Via Benzinga Earnings Scheduled For March 14, 2024 March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. Via Benzinga Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars August 28, 2023 HC Wainwright has upgraded Akebia Therapeutics Inc (NASDAQ: AKBA) from Neutral to Buy rat Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 28, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023 August 28, 2023 Via Benzinga Earnings Scheduled For August 25, 2023 August 25, 2023 Companies Reporting Before The Bell • Hibbett (NASDAQ:HIBB) is likely to report quarterly earnings at $0.73 per share on revenue of $376.11 million. Via Benzinga Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday August 25, 2023 With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows: Via Benzinga Fear & Greed Index Moves To 'Fear' Zone Ahead Of Powell's Speech August 25, 2023 The CNN Money Fear and Greed index moved to the "Fear" zone on Thursday. U.S. stocks closed sharply lower on Thursday ahead of a key speech from Federal Reserve chair Jerome Powell at the Jackson Hole... Via Benzinga Topics Economy Exposures Interest Rates 12 Health Care Stocks Moving In Tuesday's Intraday Session July 25, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 10, 2023 Via Benzinga Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 25, 2023 Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.